GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & ...

ARCpoint Inc. (the "Company" or "ARCpoint") is pleased to report that it has filed its unaudited Q1, 2025 Financial Statements and related Management Discussion and Analysis as summarized below.

ITAT Jaipur held that disallowance u/s. 40 (a) (i) of the Income Tax Act untenable since amount of commission paid to a non ...

ARCpoint Inc. (TSXV: ARC) (the "Company" or "ARCpoint") is pleased to report that it has filed its unaudited Q1, 2025 Financial Statements ...

Q1 2025 Earnings Call Transcript May 15, 2025 Operator: Good day, and thank you for standing by. Welcome to the Metals Company First Quarter 2025 Corporate Update Conference Call. At this time, all ...

Q1 2025 Earnings Call Transcript May 14, 2025 Operator: Good morning ladies and gentlemen and thank you for standing by.

For the quarter ended March 2025, Royalty Pharma (RPRX) reported revenue of $839 million, up 17% over the same period last year. EPS came in at $1.06, compared to $0.98 in the year-ago quarter.

Marshall Urist; Executive Vice President - Research and Investments; Royalty Pharma PLC Terrance Coyne; Chief Financial Officer, Executive Vice President; Royalty Pharma PLC Christopher Hite; Vice ...

The Finance Bill, 2025 arrives at a time when public trust in fiscal policy is fragile. The 2024 protests—largely driven by ...

Veteran actresses Sharmila Tagore and Simi Garewal were hailed as “royalty” as they attended ... “Simi Garewal will always be the definition of elegance,” said another.

Royalty Pharma Plc reported first-quarter 2025 earnings that fell short of analyst expectations, missing both EPS and revenue forecasts. Despite this, the company’s stock saw a slight increase ...

Raised full year 2025 guidance: Portfolio Receipts expected to be $2,975 to $3,125 million NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today reported financial results ...